Jyong Biotech Ltd. Ordinary Shares (MENS)

Jyong Biotech Ltd. Ordinary Shares (MENS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $155M; returns 1 day +1.7%, 1 week -3.8%, 1 year -97.1%.

MENS Jyong Biotech Ltd. is a clinical-stage, science-driven biotechnology company headquartered in Taiwan that specializes in the development and commercialization of plant-derived (botanical) drugs for urinary system diseases. As a pre-revenue company, its business model is entirely focused on its drug pipeline.

Groups MENS belongs to

• Biotechnology
• Clinical Stage Biotech
• Biopharmaceutical
• Pharmaceuticals
• Healthcare
• Clinical Stage
• Life Sciences

MENS financial model: income statement, cash flow and balance sheet